IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $219,428 | -81.1% | 5,348 | -82.6% | 0.00% | -83.3% |
| Q4 2022 | $1,159,879 | -83.5% | 30,709 | -83.8% | 0.01% | -85.0% |
| Q1 2022 | $7,021,000 | -13.5% | 189,556 | -29.0% | 0.04% | -9.1% |
| Q4 2021 | $8,120,000 | +80.3% | 266,845 | +181.2% | 0.04% | +18.9% |
| Q3 2020 | $4,503,000 | -31.4% | 94,905 | -7.0% | 0.04% | -79.6% |
| Q2 2019 | $6,560,000 | +1212.0% | 102,063 | +1557.9% | 0.18% | +1106.7% |
| Q1 2019 | $500,000 | -87.5% | 6,156 | -92.6% | 0.02% | -82.6% |
| Q4 2016 | $3,986,000 | – | 83,336 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |